
Transmyocardial revascularization (TMR): current status and future directions
Author(s) -
Keith B. Allen,
Amy Mahoney,
Sanjeev Aggarwal,
John R. Davis,
Elizabeth Thompson,
Alex Pak,
Jessica Heimes,
A. Michael Borkon
Publication year - 2018
Publication title -
indian journal of thoracic and cardiovascular surgery/indian journal of thoracic and cardiovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.114
H-Index - 9
eISSN - 0973-7723
pISSN - 0970-9134
DOI - 10.1007/s12055-018-0702-7
Subject(s) - medicine , cardiac surgery , population , randomized controlled trial , revascularization , coronary artery disease , vascular surgery , surgery , clinical trial , cardiology , myocardial infarction , environmental health
Cardiac surgeons are increasingly faced with a more complex patient who has developed a pattern of diffuse coronary artery disease (CAD), which is refractory to medical, percutaneous, and surgical interventions. This paper will review the clinical science surrounding transmyocardial revascularization (TMR) with an emphasis on the results from randomized controlled trials.